ArticleVeterinary research2025
Cellular hnRNP AB inhibits avian influenza virus RNA synthesis via blocking UAP56-mediated nuclear export of PB2 mRNA.
Article in Veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Shotgun proteomic analysis of quail liver under feed deprivation and low-energy diet conditions.Veterinary and animal science · 2026Article
- Cellular hnRNP D promotes influenza A virus replication by inhibiting TBK1-IRF3-mediated innate immune response.Journal of virology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Avian influenza viral ribonucleoproteins (vRNPs) complete genome transcription and replication by interacting with host proteins, and RNA-dependent RNA polymerase (RdRp) is its major component. PB2 is a component of RdRp and plays an important role in viral RNA synthesis. Our previous mass spectrometry analysis identified PB2 interacted with avian cellular heterogeneous nuclear ribonucleoprotein AB (hnRNP AB). However, the specific mechanism of this interaction regulating viral replication needs to be further clarified. In this study, we found that avian hnRNP AB inhibited the replication of multiple subtypes of avian influenza viruses (AIVs) from different reservoirs, and the glycine-rich domain (GRD) of hnRNP AB was the function domain that inhibited AIV replication. Moreover, we demonstrated that the GRD of avian hnRNP AB interacted with the C-terminus of PB2, reducing the binding of PB1 to PB2 and interfering with RdRp assembly. Based on the previous discovery that hnRNP AB affected the nucleoplasmic distribution of PB2 mRNA, we have further explored the mechanism here. Mechanically, hnRNP AB intervened in the nuclear export of PB2 mRNA by reducing the binding ability of UAP56, and decreased PB2 expression to interfere with RdRp formation and reduce vRNA synthesis, which in turn inhibited viral replication. Collectively, this study demonstrated that the avian host protein hnRNP AB inhibited AIV replication by blocking assembly of RdRp and vRNA synthesis, in which was associated with UAP56-mediated nuclear export of PB2 mRNA, providing a potential target for antiviral intervention.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.